LncRNA WDFY3-AS2 promotes cisplatin-resistant and CD44+CD166+cells in ovarian cancer by regulating the hsa-miR-139-5p/SDC4 axis (Wu et al., 2021). This evidence concerns the gene CD44 and ovarian cancer.